DNA repair capacity in peripheral lymphocytes predicts survival of patients with non-small-cell lung cancer treated with first-line platinum-based chemotherapy.
about
Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung CancerPredictive models for customizing chemotherapy in advanced non-small cell lung cancer (NSCLC)Epidemiology of Lung Cancer in Korea: Recent TrendsAberrant DNA damage response pathways may predict the outcome of platinum chemotherapy in ovarian cancerPotentially functional variants in the core nucleotide excision repair genes predict survival in Japanese gastric cancer patients.ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapyVariants in nucleotide excision repair core genes and susceptibility to recurrence of squamous cell carcinoma of the oropharynx.The prognostic value of SOX2 expression in non-small cell lung cancer: a meta-analysisERCC1 and ERCC2 variants predict survival in gastric cancer patients.DNA repair gene polymorphisms and clinical outcome of patients with primary small cell carcinoma of the esophagus.Genetic variability of DNA repair mechanisms influences chemotherapy outcome of gastric cancer.The role of SOX-2 on the survival of patients with non-small cell lung cancerPredictive assessment in pharmacogenetics of XRCC1 gene on clinical outcomes of advanced lung cancer patients treated with platinum-based chemotherapy.Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer.Formation and repair kinetics of Pt-(GpG) DNA adducts in extracted circulating tumour cells and response to platinum treatment.Association between polymorphisms in XRCC1 gene and treatment outcomes of patients with advanced gastric cancer: a systematic review and meta-analysis.DNA Adducts from Anticancer Drugs as Candidate Predictive Markers for Precision Medicine.The potential of exploiting DNA-repair defects for optimizing lung cancer treatment.Controversies and challenges regarding the impact of radiation therapy on survival.Activating adaptive cellular mechanisms of resistance following sublethal cytotoxic chemotherapy: implications for diagnostic microdosing.Microdose-Induced Drug-DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and Mice.Increased expression and function of P-glycoprotein in peripheral blood CD56+ cells is associated with the chemoresistance of non-small-cell lung cancer.Knockdown of Immature Colon Carcinoma Transcript 1 Inhibits Proliferation and Promotes Apoptosis of Non-Small Cell Lung Cancer Cells.Base excision repair pathway: PARP1 genotypes as modulators of therapy response in cervical cancer patients.Response to: "Deceptive argumentation against diagnostic microdosing of anticancer drugs" by Dirk Theile and Gerd Mikus (Letter dated February 13, 2014).ERCC1 SNPs as Potential Predictive Biomarkers in Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy.DNA repair capacity correlates with standardized uptake values from 18F-fluorodeoxyglucose positron emission tomography/CT in patients with advanced non–small-cell lung cancer.Post-treatment recovery of suboptimal DNA repair capacity and gene expression levels in colorectal cancer patientsPrognostic factors in gemcitabine-cisplatin polychemotherapy regimens in pancreatic cancer: XPD-Lys751Gln polymorphism strikes back
P2860
Q26743378-D1A37EBF-9582-4EEB-BAF1-5FD293A5D049Q27009492-5961EE84-C631-408A-BB6D-452C895D7C50Q28077423-F26D7AE4-9E2F-4CC8-9EB8-786A697F7F43Q28543351-58455B18-51B4-40F5-9675-8C3571649E5EQ31170960-6D288928-8C7F-4B5F-BF91-F2535B90AD1BQ34256001-FF19F9E0-15B0-43E3-955D-8AA1CE325848Q34555379-86DA8487-DC8B-48FB-B2FB-24B0316BCEA0Q34976982-71B5924D-2442-4E39-BA34-AC3C8198F9B4Q34983863-A1C1BB7E-0E4C-4C15-AA8C-F851466D321EQ35221075-23B8DB20-D7A3-4821-A8B6-08E581EDB945Q35741160-AFD8BA70-453B-4837-9592-B4CBF336CED7Q35909244-052D4F1C-6D3D-4F81-BD27-89EA7FDC4477Q36301463-4BC1712D-13C2-4550-9C14-D7A4C6307A5BQ36817080-AF936611-8049-485E-A7AE-C16C1005688DQ37185747-B091A717-107D-4DCE-A381-ED79908C9118Q37499473-164B294B-A589-47BF-A103-9ABD1D6A8384Q37736567-C62B2EDC-FD24-4ACD-BAC2-AE4C916E4826Q37983690-D51A0F2E-9B7B-4CEA-B8A4-0F37EFA2A823Q38035079-8BD444D8-C0AC-43B1-AD39-B0DA8EAF15E6Q38186660-84128BB2-9F90-4E77-8F01-46D1995B9E57Q38728212-4B0B8D58-A321-4EA3-815F-7A33D675F43EQ39316831-C04BBE97-0E36-41B1-B2D0-0F88B7FBA683Q39603767-F34DAA73-7E0A-43E0-8D21-E032A0946C36Q40691174-2CAC8EE0-84C5-4258-AD24-96C880E215FEQ46063558-8693D6F2-DAF7-4087-9A6D-98512C8A1D20Q53627469-2461001E-B385-493B-B163-41359A4929B4Q55506344-6051719A-B126-4329-9A25-D637AEE9540CQ57700067-2130FF30-766E-4338-BB12-F0B0DE90A47BQ57756393-34B78636-57D8-4B88-A3A6-C1BD82CEA220
P2860
DNA repair capacity in peripheral lymphocytes predicts survival of patients with non-small-cell lung cancer treated with first-line platinum-based chemotherapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
DNA repair capacity in periphe ...... e platinum-based chemotherapy.
@en
type
label
DNA repair capacity in periphe ...... e platinum-based chemotherapy.
@en
prefLabel
DNA repair capacity in periphe ...... e platinum-based chemotherapy.
@en
P2093
P2860
P356
P1476
DNA repair capacity in periphe ...... e platinum-based chemotherapy.
@en
P2093
David J Stewart
Kelly W Merriman
Qingyi Wei
Qiong Dong
P2860
P304
P356
10.1200/JCO.2010.34.3616
P407
P577
2011-09-26T00:00:00Z